MEK1/2 PATHWAY INHIBITORS PROMOTE MACROPHAGE REPARATIVE PROPERTIES AND REDUCE ACUTE AIRWAY INFLAMMATION

被引：0
|
作者：
Long, M. E. [1 ]
Eddy, W. E. [1 ]
Lovelace-Macon, L. L. [1 ]
McMahan, R. [1 ]
Gong, K. [1 ]
Liles, W. [1 ]
Manicone, A. M. [1 ]
机构：
[1] Univ Washington, Pulm & Crit Care Med, Seattle, WA 98195 USA
来源：
PEDIATRIC PULMONOLOGY | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
399
引用
收藏
页码：344 / 345
页数：2
相关论文
共 50 条
  • [1] MEK1/2 Inhibition Promotes Macrophage Reparative Properties
    Long, Matthew E.
    Eddy, William E.
    Gong, Ke-Qin
    Lovelace-Macon, Lara L.
    McMahan, Ryan S.
    Charron, Jean
    Liles, W. Conrad
    Manicone, Anne M.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (02): : 862 - 872
  • [2] THERAPEUTIC POTENTIAL OF MEK1/2 INHIBITORS TO REDUCE DETRIMENTAL LUNG INFLAMMATION
    Long, M. E.
    Gong, K.
    Volk, J. S.
    Eddy, W. E.
    Liles, W.
    Manicone, A. M.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 179 - 179
  • [3] Putative allosteric MEK1 and MEK2 inhibitors
    Price, Steve
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (06) : 603 - 627
  • [4] ANTI-INFLAMMATORY AND ANTIBACTERIAL PROPERTIES OF MEK1/2 INHIBITORS
    Long, M. E.
    Eddy, W. E.
    Hisert, K.
    Liles, W.
    Manicone, A. M.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S281 - S282
  • [5] Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling
    Little, Annette S.
    Balmanno, Kathryn
    Sale, Matthew J.
    Smith, Paul D.
    Cook, Simon J.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 73 - 78
  • [6] MEK1/2 inhibitors in the treatment of gynecologic malignancies
    Miller, Caela R.
    Oliver, Kate E.
    Farley, John H.
    GYNECOLOGIC ONCOLOGY, 2014, 133 (01) : 128 - 137
  • [7] MEK1/2 Inhibitors: Molecular Activity and Resistance Mechanisms
    Wu, Pui-Kei
    Park, Jong-In
    SEMINARS IN ONCOLOGY, 2015, 42 (06) : 849 - 862
  • [8] Intrinsic and acquired resistance to MEK1/2 inhibitors in cancer
    Sale, Matthew J.
    Cook, Simon J.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 776 - 783
  • [9] MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road
    Caunt, Christopher J.
    Sale, Matthew J.
    Smith, Paul D.
    Cook, Simon J.
    NATURE REVIEWS CANCER, 2015, 15 (10) : 577 - 592
  • [10] MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road
    Christopher J. Caunt
    Matthew J. Sale
    Paul D. Smith
    Simon J. Cook
    Nature Reviews Cancer, 2015, 15 : 577 - 592
12345